Financial Gravity Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Financial Gravity Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11	Closed	–	–	1851
2019 Q3	$0	Buy	+11	New	+$475	﹤0.01%	1718
2019 Q2	–	Sell	-6	Closed	–	–	1857
2019 Q1	$0	Buy	+6	New	+$412	﹤0.01%	1647
2018 Q3	$40K	Sell	795 -109	-12%	-$6.08K	0.04%	382
2018 Q2	$51K	Buy	904 +652	+259%	+$26K	0.05%	322
2018 Q1	$10K	Buy	+252	New	+$8.29K	0.01%	600

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Financial Gravity Asset Management's BEAT Position: Q4 2019 in Review

Financial Gravity Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 11 shares.

Financial Gravity Asset Management first reported a position in BEAT in Q1 2018 and held it in 5 quarters. The position peaked at $51K in Q2 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

Financial Gravity Asset Management reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
Financial Gravity Asset Management sold 11 BioTelemetry, Inc. shares in Q4 2019.
Financial Gravity Asset Management first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 5 quarters.
Financial Gravity Asset Management's BioTelemetry, Inc. position peaked at $51K in Q2 2018.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.